Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study

International Journal of Pharmaceutics

Volumn 497, Issue 1-2, 2016, Pages 287-292

  Fatiguso, Giovanna ^a   Allegra, Sarah ^a,b   Calcagno, Andrea ^a   Baietto, Lorena ^a   Motta, Ilaria ^a   Favata, Fabio ^a   Cusato, Jessica ^a   Bonora, Stefano ^a   Perri, Giovanni Di ^a   D'Avolio, Antonio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

ABCB1; BsmI; Cdx2; CYP24A1; FokI

Indexed keywords

COLECALCIFEROL 24 HYDROXYLASE; ETHAMBUTOL; MULTIDRUG RESISTANCE PROTEIN 1; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B1; ABCB1 PROTEIN, HUMAN; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; CELL RECEPTOR; MULTIDRUG RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER; PEROXISOME-TARGETING SIGNAL 1 RECEPTOR; SLCO1B1 PROTEIN, HUMAN; VDR PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG SCREENING; FEMALE; GENOTYPE; HUMAN; MALE; MYCOBACTERIUM TUBERCULOSIS; PHARMACOGENETICS; PLASMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; GENETICS; METABOLISM; MONONUCLEAR CELL; TIME FACTOR; TUBERCULOSIS;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ETHAMBUTOL; FEMALE; GENOTYPE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; ORGANIC ANION TRANSPORTERS; P-GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1B1; TIME FACTORS; TUBERCULOSIS; VITAMIN D3 24-HYDROXYLASE;

EID: 84954176550     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.11.044     Document Type: Article

References (17)

1. H. Arai, K.I. Miyamoto, M. Yoshida, H. Yamamoto, Y. Taketani, K. Morita, M. Kubota, S. Yoshida, M. Ikeda, F. Watabe, Y. Kanemasa, and E. Takeda The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene J. Bone Miner. Res. 16 2001 1256 1264
2. L. Baietto, A. Calcagno, I. Motta, K. Baruffi, V. Poretti, G. Di Perri, S. Bonora, and A. D'Avolio A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs J. Antimicrob. Chemother. 70 2015 2572 2575
3. I. Cascorbi, T. Gerloff, A. Johne, C. Meisel, S. Hoffmeyer, M. Schwab, E. Schaeffeler, M. Eichelbaum, U. Brinkmann, and I. Roots Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects Clin. Pharmacol. Ther. 69 2001 169 174
4. J. Cusato, S. Allegra, L. Boglione, A. De Nicolo, L. Baietto, G. Cariti, G. Di Perri, and A. D'Avolio Vitamin D pathway gene variants and HCV-2/3 therapy outcomes Antivir. Ther. 20 2014 335 341
5. J. Cusato, S. Allegra, L. Boglione, A. De Nicolo, G. Cariti, G. Di Perri, and A. D'Avolio VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia Pharmacogenet. Genomics 25 2015 164 172
6. E.F. Egelund, A. Alsultan, and C.A. Peloquin Optimizing the clinical pharmacology of tuberculosis medications Clin. Pharmacol. Ther. 98 2015 387 393
7. R.C. Hartkoorn, B. Chandler, A. Owen, S.A. Ward, S. Bertel Squire, D.J. Back, and S.H. Khoo Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein Tuberculosis (Edinb) 87 2007 248 255
8. C. Kimchi-Sarfaty, J.M. Oh, I.W. Kim, Z.E. Sauna, A.M. Calcagno, S.V. Ambudkar, and M.M. Gottesman A silent polymorphism in the MDR1 gene changes substrate specificity Science 315 2007 525 528
9. Y.R. Lou, S. Qiao, R. Talonpoika, H. Syvala, and P. Tuohimaa The role of Vitamin D3 metabolism in prostate cancer J. Steroid. Biochem. Mol. Biol. 92 2004 317 325
10. C.J. Matheny, M.W. Lamb, K.R. Brouwer, and G.M. Pollack Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation Pharmacotherapy 21 2001 778 796
11. D. Nesic, J. Cheng, and L.E. Maquat Sequences within the last intron function in RNA 3'-end formation in cultured cells Mol. Cell Biol. 13 1993 3359 3369
12. A.H. Poon, L. Gong, C. Brasch-Andersen, A.A. Litonjua, B.A. Raby, Q. Hamid, C. Laprise, S.T. Weiss, R.B. Altman, and T.E. Klein Very important pharmacogene summary for VDR Pharmacogenet. Genomics 22 2012 758 763
13. G. Ramachandran, and S. Swaminathan Role of pharmacogenomics in the treatment of tuberculosis: a review Pharmgenomics Pers. Med. 5 2012 89 98
14. M. Saeki, K. Kurose, M. Tohkin, and R. Hasegawa Identification of the functional vitamin D response elements in the human MDR1 gene Biochem. Pharmacol. 76 2008 531 542
15. N.N. Salama, Z. Yang, T. Bui, and R.J. Ho MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells J. Pharm. Sci. 95 2006 2293 2308
16. WHO, 2008. Implementing the WHO Stop TB Strategy: A Handbook for National Tuberculosis Control Programmes.
17. H. Yamamoto, K. Miyamoto, B. Li, Y. Taketani, M. Kitano, Y. Inoue, K. Morita, J.W. Pike, and E. Takeda The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine J. Bone Miner. Res. 14 1999 240 247